[Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].

作者：Yong‐Xin Li, Qingsong Yin, Hao Ai, Ruihua Mi, Lina Zhang, Yufu Li, Xudong Wei, Yongping Song · 发表于：PubMed · 年份：2019 · DOI：10.3760/cma.j.issn.0376-2491.2019.08.008 · 被引用次数：4 · 研究领域：Lymphoma Diagnosis and Treatment、Sarcoma Diagnosis and Treatment、Neuroblastoma Research and Treatments

Rituximab combined with the modified NHL-BFM-90 protocol was highly effective for children and adolescents with BL, and significantly improved long-term survival.